Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b

The recent development of direct-acting antiviral agents (DAAs) against hepatitis C virus (HCV) infection could lead to higher sustained virological response (SVR) rates, with shorter treatment durations and fewer adverse events compared with regimens that include interferon. However, a relatively s...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:World J Gastroenterol
Main Authors: Kanda, Tatsuo, Nirei, Kazushige, Matsumoto, Naoki, Higuchi, Teruhisa, Nakamura, Hitomi, Yamagami, Hiroaki, Matsuoka, Shunichi, Moriyama, Mitsuhiko
Formato: Artigo
Idioma:Inglês
Publicado: Baishideng Publishing Group Inc 2017
Assuntos:
Minireviews
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5739919/
https://ncbi.nlm.nih.gov/pubmed/29290649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v23.i46.8120
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares